Last reviewed · How we verify
Peanut SLIT-tablet — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Peanut SLIT-tablet (Peanut SLIT-tablet) — ALK-Abelló A/S.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Peanut SLIT-tablet TARGET | Peanut SLIT-tablet | ALK-Abelló A/S | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Peanut SLIT-tablet CI watch — RSS
- Peanut SLIT-tablet CI watch — Atom
- Peanut SLIT-tablet CI watch — JSON
- Peanut SLIT-tablet alone — RSS
Cite this brief
Drug Landscape (2026). Peanut SLIT-tablet — Competitive Intelligence Brief. https://druglandscape.com/ci/peanut-slit-tablet. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab